Some melanomas develop a striking avidity for lymphatic spread. In spite of multiple recurrences, patients can remain years without visceral metastasis. There is clearly a biologic reason for this lymphotrophic pattern of growth and dissemination, which we have yet to uncover. In-transit metastases have widely diverse clinical presentations and can be a stubborn disease to cure. As a result, a host of treatments exist that should be tailored to the individual patient.
Keywords: diphenylcyclopropenone; in transit; intralesional therapy; limb perfusion; melanoma, stage III; talimogene laherparepvec.
© 2018 Wiley Periodicals, Inc.